Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06203314
Status:
RECRUITING
Last Update Posted:
2024-01-12
First Post:
2023-12-29
Brief Title:
Epstein-Barr Virus and Cancer Risks
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Study Overview
Official Title:
Prospective Cohort Study on Epstein-Barr Virus Antibody and Cancer Risks
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EBVCR
Brief Summary:
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus EBV antibody levels and the risk of overall and site-specific cancer types in Southern China The main questions it aims to answer are
Question 1 In addition to the established EBV-associated cancer types such as lymphomas nasopharyngeal carcinoma and stomach cancer whether EBV is associated with other cancer types Question 2 Whats the cancer burden attributed to EBV in Southern China
Question 1 In addition to the established EBV-associated cancer types such as lymphomas nasopharyngeal carcinoma and stomach cancer whether EBV is associated with other cancer types Question 2 Whats the cancer burden attributed to EBV in Southern China
Detailed Description:
Growing molecular evidence suggests the involvement of EBV in various cancers however comprehensive epidemiological evidence is still lacking In this study researchers conducted a population-based prospective cohort study to investigate the associations between EBV antibodies and the risk of overall and site-specific cancer types in Southern China All the participants underwent EBV antibody tests at enrollment and were subsequently followed up annually for cancer incidence vital status and immigration status The primary objective of this study was to provide prospective evidence for the role of EBV in multiple cancers shedding light on the etiology of a broad range of common EBV-associated cancers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None